AUBN vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AUBN exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. The stock trades below its Graham Number of $34.65 at $26.25, suggesting potential undervaluation, though growth expectations are modest with a P/E of 12.62 and strong recent earnings growth. Profitability metrics like a 22.11% profit margin and 32.92% operating margin are solid, but low ROA of 0.71% and missing leverage data raise concerns. Dividend strength is high with a 4.17% yield and sustainable 52.68% payout ratio, but technical trend is bearish and insider sentiment is neutral.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AUBN vs JPM: Head-to-Head Comparison
This page compares Auburn National Bancorporation, Inc. (AUBN) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.